Literature DB >> 21404117

Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies.

Karin Hardt1, Sven Boris Heick, Beate Betz, Timm Goecke, Haniyeh Yazdanparast, Robin Küppers, Kati Servan, Verena Steinke, Nils Rahner, Monika Morak, Elke Holinski-Feder, Christoph Engel, Gabriela Möslein, Hans-Konrad Schackert, Magnus von Knebel Doeberitz, Christian Pox, Johannes H Hegemann, Brigitte Royer-Pokora.   

Abstract

Missense mutations of the DNA mismatch repair gene MLH1 are found in a significant fraction of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC) and their pathogenicity often remains unclear. We report here all 88 MLH1 missense variants identified in families from the German HNPCC consortium with clinical details of these patients/families. We investigated 23 MLH1 missense variants by two functional in vivo assays in yeast; seven map to the ATPase and 16 to the protein interaction domain. In the yeast-2-hybrid (Y2H) assay three variants in the ATPase and twelve variants in the interaction domain showed no or a reduced interaction with PMS2; seven showed a normal and one a significantly higher interaction. Using the Lys2A (14) reporter system to study the dominant negative mutator effect (DNE), 16 variants showed no or a low mutator effect, suggesting that these are nonfunctional, three were intermediate and four wild type in this assay. The DNE and Y2H results were concordant for all variants in the interaction domain, whereas slightly divergent results were obtained for variants in the ATPase domain. Analysis of the stability of the missense proteins in yeast and human embryonic kidney cells (293T) revealed a very low expression for seven of the variants in yeast and for nine in human cells. In total 15 variants were classified as deleterious, five were classified as variants of unclassified significance (VUS) and three were basically normal in the functional assays, P603R, K618R, Q689R, suggesting that these are neutral.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21404117     DOI: 10.1007/s10689-011-9431-4

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  33 in total

Review 1.  The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.

Authors:  R Fishel
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

2.  The distribution of the numbers of mutants in bacterial populations.

Authors:  D E LEA; C A COULSON
Journal:  J Genet       Date:  1949-12       Impact factor: 1.166

3.  The effect of genetic background on the function of Saccharomyces cerevisiae mlh1 alleles that correspond to HNPCC missense mutations.

Authors:  Jennifer J Wanat; Nikhil Singh; Eric Alani
Journal:  Hum Mol Genet       Date:  2007-01-08       Impact factor: 6.150

4.  The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2.

Authors:  E Kondo; A Horii; S Fukushige
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

5.  Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.

Authors:  Joerg Trojan; Stefan Zeuzem; Ann Randolph; Christine Hemmerle; Angela Brieger; Jochen Raedle; Guido Plotz; Josef Jiricny; Giancarlo Marra
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

Review 7.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

8.  Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).

Authors:  Elizabeth C Chao; Jonathan L Velasquez; Mavee S L Witherspoon; Laura S Rozek; David Peel; Pauline Ng; Stephen B Gruber; Patrice Watson; Gad Rennert; Hoda Anton-Culver; Henry Lynch; Steven M Lipkin
Journal:  Hum Mutat       Date:  2008-06       Impact factor: 4.878

9.  Functional analysis of human MutSalpha and MutSbeta complexes in yeast.

Authors:  A B Clark; M E Cook; H T Tran; D A Gordenin; M A Resnick; T A Kunkel
Journal:  Nucleic Acids Res       Date:  1999-02-01       Impact factor: 16.971

Review 10.  Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).

Authors:  Andre Fedier; Daniel Fink
Journal:  Int J Oncol       Date:  2004-04       Impact factor: 5.650

View more
  7 in total

1.  Full-length transcript amplification and sequencing as universal method to test mRNA integrity and biallelic expression in mismatch repair genes.

Authors:  Monika Morak; Kerstin Schaefer; Verena Steinke-Lange; Udo Koehler; Susanne Keinath; Trisari Massdorf; Brigitte Mauracher; Nils Rahner; Jessica Bailey; Christiane Kling; Tanja Haeusser; Andreas Laner; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2019-07-22       Impact factor: 4.246

2.  Q48P mutation in the hMLH1 gene associated with Lynch syndrome in three Hungarian families.

Authors:  Miklós Tanyi; Judit Olasz; Janos L Tanyi; László Tóth; Péter Antal-Szalmás; Tamás Bubán; Csilla András; Hilda Urbancsek; Zoltán Garami; Orsolya Csuka; László Damjanovich
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 3.  The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome.

Authors:  Juana V Martín-López; Richard Fishel
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

4.  C-terminal fluorescent labeling impairs functionality of DNA mismatch repair proteins.

Authors:  Angela Brieger; Guido Plotz; Inga Hinrichsen; Sandra Passmann; Ronja Adam; Stefan Zeuzem
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

5.  Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation.

Authors:  Jenny von Salomé; Tao Liu; Markku Keihäs; Moni Morak; Elke Holinski-Feder; Ian R Berry; Jukka S Moilanen; Stéphanie Baert-Desurmont; Annika Lindblom; Kristina Lagerstedt-Robinson
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

6.  Identification of MLH2/hPMS1 dominant mutations that prevent DNA mismatch repair function.

Authors:  Gloria X Reyes; Boyu Zhao; Tobias T Schmidt; Kerstin Gries; Matthias Kloor; Hans Hombauer
Journal:  Commun Biol       Date:  2020-12-10

7.  Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients.

Authors:  Muhammad Usman Rashid; Humaira Naeemi; Noor Muhammad; Asif Loya; Jan Lubiński; Anna Jakubowska; Muhammed Aasim Yusuf
Journal:  Hered Cancer Clin Pract       Date:  2019-10-23       Impact factor: 2.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.